In 2021, we were proud to honor some wonderful pharmacy compounding professionals who make a big difference in their communities. We presented our annual awards to these extraordinary and deserving compounders in October and November this year.

Andrew Glasnapp helps you understand which form of lidocaine to use in different situations by explaining the chemical and physical properties, clinical considerations, common dosages, and safety and toxicity factors for both lidocaine and lidocaine hydrochloride.

Congratulations to Kevin Hennessy of The Compounding Pharmacist in West Chester, Pennsylvania for being our December Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of pharmacy compounding by providing the highest quality of service to their patients.

Bill Letendre walks you through the four main categories of business goals, according to experts. (Hint: They're not all financial.) He also explains why each type is important for pharmacies and provides tips for setting and achieving your goals.

A.J. Day outlines how the FDA PCAC process works as well as a major development that happened with methylcobalamin at the 2021 PCAC meeting. He then explains how compounding pharmacies can help to further the process now.

From up-to-date clinical information to business tips aimed at helping pharmacies thrive, our experts captured some of the most exciting information at International Seminar 2021. We pulled together over 20 gems from their notes so that you can see some of the highlights here.

PCCA's Erin Michael interviewed Liza Chapman of the Pharmacy Technician Certification Board to get her thoughts on how pharmacy technicians have evolved and will continue to over the years. Liza also provided advice for new technicians as well as experienced one.

Congratulations to John Anderson of Wimberley Pharmacy in Wimberley, Texas for being our November Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of pharmacy compounding by providing the highest quality of service to their patients.

Matt Martin points out the most significant change in the newly proposed version of USP Chapter 797 as well as the cascading effects it has on the guidelines. He also explains the process for the proposed version to become official and what compounding pharmacies and other stakeholders should do about it now.

Matt Martin highlights four key changes in the newly proposed version of USP Chapter 795 that may have significant implications for compounding pharmacies. He also explains what the process will look like for the proposed version to become official and suggests what compounders should do about it now.